ASSESSMENT OF MINIMAL RESIDUAL DISEASE BY NEXT-GENERATION FLOW CYTOMETRY AFTER INITIAL INDUCTION THERAPY FOR ACUTE MYELOID LEUKEMIA IN A PUBLIC PEDIATRIC HOSPITAL MCC Magalhães; RM Pontes; FM Furtado; BC Guido; ACMD Santos-Junior; RA Toscano; IMQ Magalhães; R Camargo; JCM Códoba;

RELIABLE FLOW CYTOMETRY METHOD FOR MONITORING OF MINIMAL RESIDUAL DISEASE IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA AFTER BLINATUMOMAB THERAPY RM Pontes; FM Furtado; SCR Franco; RA Toscano; TF Nunes; ACS Dias; JCM Cordoba; ACMDS Junior; R Camargo; IMM Quezado;

BLINATUMOMAB: ANALYSIS OF OVERALL SURVIVAL AND DISEASE-FREE SURVIVAL IN PEDIATRIC PATIENTS DIAGNOSED WITH RELAPSED/REFRACTORY PH-NEGATIVE B-ALL TF Nunes; RM Pontes; ACS Dias; JCM Córdoba; IMQ Magalhães; R Camargo; FM Furtado;